Moon Surgical receives FDA clearance for ScoPilot™ on Maestro, industry’s first AI-enhanced intraoperative capability, powered by NVIDIA Holoscan
PARIS and SAN FRANCISCO, March 18, 2025 /PRNewswire/ — Moon Surgical, a French-American pioneer in surgical innovation, announced today the United States Food and Drug Administration (FDA) clearance for ScoPilot. Enabled by NVIDIA Holoscan, a real-time sensing platform designed to develop and deploy applications based on Artificial Intelligence in the operating room, and running locally on Moon Surgical’s Maestro System. ScoPilot is the first AI application to run intraoperatively on any commercially available surgical robotic platform with Holoscan.
